Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide
These findings suggest a potential therapeutic role for defibrotide in managing intestinal aGVHD by improving epithelial barrier integrity and reducing inflammation-related damage.
Authors
- Erika Rimondi (ORCID: https://orcid.org/0000-0002-8241-2513)
- Paola Secchiero (ORCID: https://orcid.org/0000-0003-4101-7987)
- Stefania Braidotti (ORCID: https://orcid.org/0000-0002-7463-5776)
- E. Melloni (ORCID: https://orcid.org/0000-0002-7829-0824)
- Natalia Maximova (ORCID: https://orcid.org/0000-0003-0934-1875)
- Annalisa Marcuzzi (ORCID: https://orcid.org/0000-0003-3427-618X)
Institutions
- University of Ferrara (IT)
- IRCCS Materno Infantile Burlo Garofolo (IT)
Publication Details
- Journal
- Journal of Experimental Pharmacology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/jep.s534739
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Università degli Studi di Ferrara